Welcome to our dedicated page for Almaden Mineral SEC filings (Ticker: AAUAF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Almaden Minerals Ltd. (AAUAF) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures as a foreign private issuer, along with AI-supported tools to help interpret them. Almaden files its annual report on Form 20-F and furnishes Form 6-K current reports under the Securities Exchange Act of 1934, providing investors with financial statements, management’s discussion and analysis, certifications of interim filings, and key press releases.
For a gold-sector basic materials company like Almaden, these filings offer insight into the financial impact of the loss of the Ixtaca project mineral concessions in Mexico, the structure and terms of its non-recourse litigation funding, and the progress of its international arbitration claim under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership. Form 6-K submissions referenced in recent disclosures include exhibits such as financial statements, MD&A, and press releases that describe arbitration milestones, amendments to a gold loan with Almadex Minerals Ltd., and the company’s agreement to sell certain Rock Creek Mill assets.
On this page, users can review Almaden’s 20-F annual report for a consolidated view of its operations and risks, and track 6-K filings for interim updates on legal proceedings, financing arrangements, asset transactions, and listing changes, including the move from NYSE American to the OTCQB marketplace. Stock Titan’s AI-powered summaries highlight the main points of lengthy documents, helping readers quickly understand what each filing says about Almaden’s strategy, capital structure, and exposure to the Ixtaca arbitration.
In addition to core financial and narrative disclosures, this page also surfaces any available information on executive certifications and other exhibits attached to Almaden’s SEC submissions, giving investors a structured way to follow the company’s regulatory record over time.
Almaden Minerals Ltd. reported a much smaller comprehensive loss of $106,606 for the three months ended March 31, 2026, compared with $1,316,336 a year earlier, as financing costs tied to a repaid gold loan dropped and other income improved.
Cash and cash equivalents were $6,064,828 and working capital was $5,798,631, supporting management’s conclusion that the company can fund operations for the next twelve months. The company remains an exploration-stage issuer focused on its international arbitration claim against Mexico under the CPTPP, where it is seeking US$1.06 billion in damages and is funded by a non‑recourse litigation finance facility.
Almaden Minerals Ltd. has filed a report detailing its upcoming Meeting of Security Holders. The Annual General and Special Meeting is scheduled for June 25, 2026 in Vancouver. Shareholders of record as of May 20, 2026 will be entitled to receive notice and vote.
The same date, May 20, 2026, is used as the record date for notice, voting, and beneficial ownership determination. The company will not use notice-and-access for either registered or beneficial holders and will not send proxy materials directly to NOBOs or pay for delivery to OBOs.
Almaden Minerals Ltd. is a Canadian mineral exploration company that currently has no revenue from mining operations and reports under IFRS. It had 137,363,181 common shares outstanding as of December 31, 2025.
After a large non‑cash impairment of the Tuligtic/Ixtaca project in 2023, Almaden reported a net loss of $64,148,145 for 2023, a narrower loss of $2,875,061 for 2024, and net income of $2,989,046 for 2025. The 2025 profit mainly reflects a $4,684,164 gain on the sale of Rock Creek mill equipment and foreign exchange movements, not operating mining income.
The company’s Mexican mineral concessions underlying the Ixtaca project were cancelled by Mexican authorities, leading Almaden and affiliate Almadex to start international arbitration under the CPTPP at ICSID. They are seeking aggregate damages of US$1.06 billion, which Mexico contests, and a three‑person panel has set hearings for December 2026.
Almaden is funding the case through a non‑recourse litigation funding agreement providing up to US$9.5 million; US$4,000,000 had been disbursed by December 31, 2025. The company also realized net proceeds of US$8,245,000 from the Rock Creek asset sale and ended 2025 with working capital of $5,910,941, including cash and cash equivalents of $6,171,157, which management believes is sufficient for the next year.
Almaden remains an exploration‑stage issuer with a history of net losses, no dividend history, and significant risk factors, including reliance on a single major legal claim in Mexico, commodity price volatility, potential shareholder dilution from 11,635,000 outstanding options, and tax and regulatory risks such as possible PFIC classification for U.S. investors.
Almaden Minerals Ltd. reported a strong turnaround in 2025, earning net income of $2,989,046 after losses in 2024 and 2023. The improvement was driven mainly by a $4,684,164 gain on the sale of the Rock Creek Mill and repayment of its gold loan.
Total assets were $6,693,338 at December 31, 2025, with total liabilities reduced sharply to $626,310 after eliminating the $8,128,263 gold loan payable. Cash and cash equivalents rose to $6,171,157, giving working capital of $5,910,941 and supporting the going-concern assessment.
The company continues to focus on international arbitration against Mexico over the revoked Ixtaca mineral concessions. Together with Almadex, it is seeking aggregate damages of US$1.06 billion under the CPTPP, funded by up to US$9.5 million of non-recourse litigation financing, with hearings scheduled for December 2026.